Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Neurology(R) Neuroimmunology & Neuroinflammation|June 29, 2023
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case ReportLea Grote-Levi, Nora Möhn, Agnes Bonifacius, et al.Frontiers in Immunology|April 24, 2023
Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedureSabine Tischer-Zimmermann, Elisabeth Salzer, Tamires Bitencourt, et al.Journal of Clinical Immunology|January 6, 2022
Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised PatientsFriederike C Schulze Lammers, Agnes Bonifacius, Sabine Tischer-Zimmermann, et al.Blood Advances|March 15, 2019
Modulation of TAP-dependent antigen compartmentalization during human monocyte-to-DC differentiationMarius Döring, Hanna Blees, Nicole Koller, et al.Therapeutic Advances in Neurological Disorders|May 30, 2024
Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case reportSandra Nay, Nora Möhn, Lea Grote-Levi, et al.Journal for Immunotherapy of Cancer|October 31, 2020
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferationAnna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, et al.Blood Advances|December 21, 2023
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISMAlice Felicitas Rein, Chris David Lauruschkat, Ihsan Muchsin, et al.HLA|June 26, 2024
Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunityMaria Michela Santamorena, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.Molecular Therapy. Oncology|July 13, 2026
Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignanciesAgnes Bonifacius, Philip Mausberg, Friederike Floegel, et al.JAMA Neurology|October 7, 2024
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Mike P Wattjes, et al.Pageof 3